[Evaluation of results of enucleations with orbital implant in children and adolescents].
OBJECTIVE
The aim of the research is the assessment of results of enucleation with orbital implant in children.


METHODS
Examinations included the group of 99 children between 6 months and 19 years of age. The examined group consisted of 39 boys (39.4%) and 60 girls (60.6%). 96 eyes were removed because of non-regressive retinoblastoma (despite applied treatment), two eyes with buphtalmus (with no light perception), as a result of glaucoma, and one case of medulloepithelioma. The applied implants were: Castroviejo--in 28 patients, Medpor--in 24 patients, Hydroxyapatite--46 patients. In one patient was applied Baush and Lomb orbital implant.


RESULTS
In 91 patients (91.9%) no significant complications occurred. In 2 patients (2%), the hemorrhage occurred during the surgery. Postoperative complications included: in 6 patients (6.1%) exposition of orbital implant was observed; in one patient the exposition was enlarging which led to removal of the implant; in 2 patients with implant exposition (2%) inflammatory granuloma occurred on the edge of the exposition. In one patient (1%) cyst of conjunctiva in the postoperative scar area occurred 3 months after operation.


CONCLUSIONS
Enucleation with orbital implant enables normal development of the orbit and improves cosmetic effect. The frequency of complications depends on type of applied orbital implant.
Hautz
Wojciech
W
Kliniki Okulistyki Instytutu "Pomnik - Centrum Zdrowia Dziecka" w Warszawie.
Grałek
Mirosława
M
Karczmarewicz
Beata
B
Kanigowska
Krystyna
K
Klimczak-Slaczka
Dorota
D
Chipczyńska
Barbara
B
D000293:Adolescent; D000328:Adult; D001672:Biocompatible Materials; D002648:Child; D002675:Child, Preschool; D017886:Durapatite; D015353:Eye Enucleation / Q000379:methods*; D005130:Eye Hemorrhage / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006099:Granuloma / Q000209:etiology; D006801:Humans; D007223:Infant; D008297:Male; D020273:Orbital Implants / Q000009:adverse effects / Q000145:classification; D011095:Polyethylenes; D019919:Prosthesis Implantation / Q000379:methods; D012175:Retinoblastoma / Q000601:surgery*; D016896:Treatment Outcome
D001672:Biocompatible Materials; C084562:Medpor; D011095:Polyethylenes; D017886:Durapatite